The percentage describes only one dimension
A concentration tells you how much of an ingredient is in the preparation. It does not, by itself, describe the base, companion actives, application directions or the person using it. Those differences can make two superficially similar creams quite different choices.
This publication does not label the highest percentage the best or provide a ladder for increasing strength.
Irritation is relevant to the decision
AAD discusses irritation as a practical limitation of retinoid use. A plan that is difficult to tolerate needs clinical attention, not an assumption that discomfort proves the treatment is working.[source]
Tell the clinician about previous reactions and the surrounding routine. The appropriate response depends on the symptoms and actual preparation; a website cannot choose it from a concentration alone.
The whole formula deserves attention
A multi-ingredient cream may include additional actives for a particular concern. That does not establish that the blend is uniformly gentler or more effective. Ask why the combination was chosen and what evidence supports the specific claim.
FDA distinguishes compounded preparations from approved finished medicines. The ingredient’s familiarity does not erase that evidence boundary.[source]
Comparative claims need a comparator
A statement such as stronger or gentler requires a named comparison and an outcome. Agency’s Night Renew page uses such claims while also explaining that formulas vary. Read the qualifications alongside the headline.[source]
A useful comparison includes follow-up
Compare the clinician’s rationale, product version and follow-up route alongside concentration and cost. Ask when the decision will be reassessed. Changing strengths should follow the treating professional’s plan, not a ranking assembled from unrelated product pages.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- American Academy of Dermatology — Retinoid or retinol?Dermatology guidance on retinoids, irritation and pregnancy
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations
- Agency — Night Renew RxProduct page; not every personalized formula contains tretinoin